| Hazard Information | Back Directory | [Uses]
BBDDL2059 is a selective covalent inhibitor of histone methyltransferase EZH2 with an IC50 of 1.5 nM for EZH2-Y641F. BBDDL2059 inhibits lymphoma cell growth at nanomolar concentrations and can be used for anticancer research[1]. | [IC 50]
EZH2 Y641F mutant type: 1.5 nM (IC50) | [References]
[1] Zhang Y, et.al. Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2. J Med Chem. 2023 Jun 8;66(11):7629-7644. DOI:10.1021/acs.jmedchem.3c00504 |
|
|